Search

everythinglearnresearchcommunity

for

Search:↓

Further testing of paclitaxel poliglumex for this cancer treatment is not justified.

Flammulina velutipes polysaccharide helps the immune system fight tumors by activating certain pathways.

Personalized sonidegib dosing can effectively treat Gorlin-Goltz syndrome with fewer side effects.

Intravenous arsenic is safe and effective for treating certain blood cancers.

FGF18 treatment during hair's resting phase can protect against hair loss from radiation.

Chemotherapy targets all dividing cells, causing side effects like nausea and hair loss.

Safflower extract helps protect hair follicle cells from damage caused by chemotherapy.

A man's skin cancer improved and some of his hair grew back after treatment with a special light therapy and a medication.

Methotrexate may help stabilize frontal fibrosing alopecia.

A man's relapsed leprosy was successfully treated with the antibiotic sparfloxacin.

Fusidic acid successfully treated a rare scalp infection with hair regrowth and no recurrence after 6 months.

A woman with lymphoma had a rare skin rash on her scalp and forehead, which was hard to diagnose but responded well to treatment.

Dr. Mario Lacouture recommends preventive and specific treatments for skin side effects caused by EGFR inhibitors to improve patients' quality of life.

Lung cancer patients on immunotherapy and chemotherapy often experience severe fatigue, drowsiness, and appetite loss.

Topical vitamin D3 does not prevent hair loss from chemotherapy.

Isolated limb perfusion is a safe and effective treatment for limb melanoma.

Tofacitinib taken by mouth helps treat hair loss in children.

ALRN-6924 may prevent hair loss caused by chemotherapy.

The compound 4c showed strong potential as an anticancer agent.

The combination therapy is effective and well-tolerated for treating esophageal cancer.

Some breast cancer patients treated with high-dose docetaxel may experience permanent hair loss.

About 22% of cancer patients had skin-related side effects from chemotherapy, but these were usually not severe enough to halt treatment.

Oral paclitaxel plus encequidar improved tumor response and caused less neuropathy but more serious infections than intravenous paclitaxel.

No treatment fully prevents hair loss from chemotherapy yet.

Uveal melanoma is hard to treat when it spreads, but a new drug, tebentafusp, helps patients live longer.

Selumetinib effectively reduces tumor size in many children with neurofibromatosis type 1, but can cause skin and hair issues.

Targeting EGFR may help reduce hair loss from chemotherapy.

FMF and mycosis fungoides are variants of the same disease, and bexarotene can be an effective treatment.

A man with a type of skin lymphoma had unusual yellowish skin growths despite normal blood lipid levels, and treatment reduced some symptoms but not the growths.